Collplant Biotechnologies Stock Alpha and Beta Analysis

CLGN Stock  USD 4.25  0.01  0.23%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Collplant Biotechnologies. It also helps investors analyze the systematic and unsystematic risks associated with investing in Collplant Biotechnologies over a specified time horizon. Remember, high Collplant Biotechnologies' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Collplant Biotechnologies' market risk premium analysis include:
Beta
1.22
Alpha
(0.38)
Risk
3.25
Sharpe Ratio
(0.09)
Expected Return
(0.29)
Please note that although Collplant Biotechnologies alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Collplant Biotechnologies did 0.38  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Collplant Biotechnologies stock's relative risk over its benchmark. Collplant Biotechnologies has a beta of 1.22  . As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Collplant Biotechnologies will likely underperform. At this time, Collplant Biotechnologies' Book Value Per Share is very stable compared to the past year. As of the 29th of November 2024, Tangible Book Value Per Share is likely to grow to 2.59, though Enterprise Value Over EBITDA is likely to grow to (7.30).

Enterprise Value

59.31 Million

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Collplant Biotechnologies Backtesting, Collplant Biotechnologies Valuation, Collplant Biotechnologies Correlation, Collplant Biotechnologies Hype Analysis, Collplant Biotechnologies Volatility, Collplant Biotechnologies History and analyze Collplant Biotechnologies Performance.
To learn how to invest in Collplant Stock, please use our How to Invest in Collplant Biotechnologies guide.

Collplant Biotechnologies Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Collplant Biotechnologies market risk premium is the additional return an investor will receive from holding Collplant Biotechnologies long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Collplant Biotechnologies. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Collplant Biotechnologies' performance over market.
α-0.38   β1.22

Collplant Biotechnologies expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Collplant Biotechnologies' Buy-and-hold return. Our buy-and-hold chart shows how Collplant Biotechnologies performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Collplant Biotechnologies Market Price Analysis

Market price analysis indicators help investors to evaluate how Collplant Biotechnologies stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Collplant Biotechnologies shares will generate the highest return on investment. By understating and applying Collplant Biotechnologies stock market price indicators, traders can identify Collplant Biotechnologies position entry and exit signals to maximize returns.

Collplant Biotechnologies Return and Market Media

The median price of Collplant Biotechnologies for the period between Sat, Aug 31, 2024 and Fri, Nov 29, 2024 is 4.56 with a coefficient of variation of 11.15. The daily time series for the period is distributed with a sample standard deviation of 0.5, arithmetic mean of 4.51, and mean deviation of 0.44. The Stock received some media coverage during the period.
 Price Growth (%)  
       Timeline  
1
CollPlant Biotechnologies Ltd. Short Interest Up 5.3 percent in September
10/02/2024
2
CollPlant to Report Q3 2024 Earnings on Nov 27 Conference Call Details CLGN Stock News - StockTitan
11/12/2024
3
What To Expect From CollPlant Biotechnologies Ltd Q3 2024 Earnings
11/26/2024

About Collplant Biotechnologies Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Collplant or other stocks. Alpha measures the amount that position in Collplant Biotechnologies has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2021 2022 2023 2024 (projected)
Days Sales Outstanding6.310.9913.0912.43
PTB Ratio3.612.852.574.81

Collplant Biotechnologies Upcoming Company Events

As portrayed in its financial statements, the presentation of Collplant Biotechnologies' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Collplant Biotechnologies' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Collplant Biotechnologies' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Collplant Biotechnologies. Please utilize our Beneish M Score to check the likelihood of Collplant Biotechnologies' management manipulating its earnings.
3rd of April 2024
Upcoming Quarterly Report
View
22nd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
3rd of April 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with Collplant Biotechnologies

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Collplant Biotechnologies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Collplant Biotechnologies' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Collplant Biotechnologies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Collplant Biotechnologies Stock:
Collplant Biotechnologies technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Collplant Biotechnologies technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Collplant Biotechnologies trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...